| Product Code: ETC12463461 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Imatinib Drug Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Imatinib Drug Market - Industry Life Cycle |
3.4 Greece Imatinib Drug Market - Porter's Five Forces |
3.5 Greece Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Greece Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Greece Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Greece Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Greece Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Greece Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST) in Greece |
4.2.2 Rising awareness about the effectiveness of Imatinib in treating these diseases |
4.2.3 Government initiatives to improve access to essential medications |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Greece |
4.3.2 Competition from generic Imatinib drugs |
4.3.3 High cost of Imatinib treatment for patients in Greece |
5 Greece Imatinib Drug Market Trends |
6 Greece Imatinib Drug Market, By Types |
6.1 Greece Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Greece Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Greece Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Greece Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Greece Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Greece Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Greece Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Greece Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Greece Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Greece Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Greece Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Greece Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Greece Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Greece Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Greece Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Greece Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Greece Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Greece Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Greece Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Greece Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Greece Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Greece Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Greece Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Greece Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Greece Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Greece Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Greece Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Greece Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Greece Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Greece Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Greece Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Greece Imatinib Drug Market Import-Export Trade Statistics |
7.1 Greece Imatinib Drug Market Export to Major Countries |
7.2 Greece Imatinib Drug Market Imports from Major Countries |
8 Greece Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to Imatinib treatment |
8.2 Number of healthcare facilities prescribing Imatinib |
8.3 Rate of diagnosis of CML and GIST cases in Greece |
9 Greece Imatinib Drug Market - Opportunity Assessment |
9.1 Greece Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Greece Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Greece Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Greece Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Greece Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Greece Imatinib Drug Market - Competitive Landscape |
10.1 Greece Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Greece Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here